Risk factors for developing renal stones in inflammatory bowel disease

BJU International

Volumn 89, Issue 9, 2002, Pages 835-841

  McConnell, N ^a   Campbell, S ^a,b   Gillanders, I ^c   Rolton, H ^a   Danesh, B ^a,b  

^a STOBHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Calculi; Crohn's disease; Hyperoxaluria; Magnesium; Ulcerative colitis

Indexed keywords

CALCIUM; CALCIUM OXALATE; CITRIC ACID; CREATININE; MAGNESIUM; OXALIC ACID; URATE;

ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COLON; CONTROLLED STUDY; CORRELATION ANALYSIS; COVARIANCE; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; HYPEROXALURIA; KIDNEY EXAMINATION; MALE; NEPHROLITHIASIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; ULCERATIVE COLITIS; URINALYSIS; URINE LEVEL;

ACUTE-PHASE PROTEINS; ADULT; AGED; C-REACTIVE PROTEIN; CITRATES; COLITIS, ULCERATIVE; CREATININE; CROHN DISEASE; FEMALE; HUMANS; HYPEROXALURIA; KIDNEY CALCULI; MAGNESIUM; MALABSORPTION SYNDROMES; MALE; MIDDLE AGED; OXALATES; RISK FACTORS; SERUM ALBUMIN;

EID: 0036094069     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2002.02739.x     Document Type: Article

References (20)

1. Genitourinary complications of inflammatory bowel disease
2. Cholelithiasis and urolithiasis in Crohn's disease
3. Urinary factors of kidney stone formation in patients with Crohn's disease
4. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel
5. The pathogenesis and treatment of kidney stones
6. Acquired hyperoxaluria, nephrolithiasis and intestinal disease
7. Urolithiasis and hyperoxaluria in chronic inflammatory bowel disease
8. A fast automated method for measuring serum and urine citrate
9. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease
10. Urinary citrate excretion in patients with urolithiasis and normal subjects
11. Studies on urine composition in patients with calcium oxalate stone disease
12. Renal stone formation in patients with inflammatory bowel disease
13. Nephrolithiasis in inflammatory bowel disease
14. Management of patients with a short bowel
15. Nephrolithiasis and urine ion changes in ulcerative colitis patients undergoing colectomy and endorectal pullthrough
16. Magnesium deficiency after ileal resection for Crohn's disease
17. The importance of urinary magnesium values in patients with gut failure
18. Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid
19. Treatment of enteric hyperoxaluria
20. Hypocitraturia in patients with gastrointestinal malabsorption